Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3692755019 | Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3692756018 | Benzocaine 20 mg/g and chloroxylenol 1.06 mg/g oromucosal gel | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 46761301000001113 | Benzocaine 2% / Chloroxylenol 0.106% oral gel sugar free | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 62013101000001118 | Benzocaine 2% / Chloroxylenol 0.106% oromucosal gel sugar free | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Is a | Compound anesthetic topical preparation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has active ingredient | Local anesthetic | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Is a | Product containing benzocaine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Is a | Product containing chloroxylenol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has active ingredient | Chlorinated phenol disinfectant | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has active ingredient | Skin agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has active ingredient | Benzocaine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has active ingredient | Chloroxylenol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has active ingredient | Phenol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Is a | Product containing benzocaine and chloroxylenol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has manufactured dose form | Gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has manufactured dose form | Conventional release oromucosal gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Is a | Product manufactured as oromucosal dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has basis of strength substance | Chloroxylenol | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has concentration strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has precise active ingredient | Chloroxylenol | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has concentration strength numerator value | 1.06 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has basis of strength substance | Benzocaine | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has precise active ingredient | Benzocaine | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Is a | Product containing only benzocaine and chloroxylenol in oromucosal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has basis of strength substance | Chloroxylenol | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has precise active ingredient | Chloroxylenol | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has basis of strength substance | Benzocaine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has precise active ingredient | Benzocaine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has active ingredient | Chloroxylenol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Is a | Benzocaine + Chloroxylenol | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has manufactured dose form | Conventional release oromucosal gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oromucosal route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Continuous dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | gel.oromucosal ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has active ingredient | 4-Chloro-3,5- xylenol | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has manufactured dose form | Gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has manufactured dose form | Oromucosal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has manufactured dose form | Conventional release oromucosal gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has NHS dm+d (dictionary of medicines and devices) freeness indicator | Sugar free | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has active ingredient | Benzocaine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has manufactured dose form | Conventional release oromucosal gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has manufactured dose form | Gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has manufactured dose form | Gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has specific active ingredient | Chloroxylenol | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has specific active ingredient | Benzocaine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has dispensed dose form | Gel | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has dispensed dose form | Conventional release oromucosal gel | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Has manufactured dose form | Conventional release oromucosal gel | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Benzocaine+chloroxylenol 2%/0.106% gel - product | Is a | False | Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Inferred relationship | Existential restriction modifier | |
| Rinstead Adult gel (Schering-Plough Ltd) | Is a | True | Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Inferred relationship | Existential restriction modifier | |
| Benzocaine 2% / Chloroxylenol 0.106% oral gel sugar free 15 gram | Is pack of | False | Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Inferred relationship | Existential restriction modifier | |
| Benzocaine 2% / Chloroxylenol 0.106% oral gel sugar free 15 gram | Has VMP | True | Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR